How many institutional investors hold HUM?

6 tracked institutional investors disclosed a position in HUM (HUMANA INC) in their most recent 13F filing.

Who is the largest institutional holder of HUM?

Ken Griffin, Citadel Advisors, holds the largest disclosed position in HUM, valued at $313M.

What sector is HUM in?

HUMANA INC is classified in the Health Care GICS sector, Healthcare Plans industry.

Where does this HUM ownership data come from?

SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.

HUM — HUMANA INC

Name: HUMANA INC (HUM) — Institutional Ownership
Creator: InvestorLens
License: https://www.sec.gov/about/website-policies

Health Care · Healthcare Plans

For educational research only.InvestorLens analyzes public regulatory filings (SEC EDGAR, STOCK Act PTRs) that may be delayed by 45 days or more. Information shown is historical and is not financial, legal, or tax advice, nor a recommendation or solicitation to buy or sell any security. Always do your own research.

InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.

Sourced from SEC EDGAR public filings

About HUMANA INC (HUM)

HUMANA INC (HUM) appears in the most recent 13F filings of 6 tracked institutional investors. HUMANA INC is classified in the Health Care sector (Healthcare Plans industry). The largest disclosed position is held by Ken Griffin (Citadel Advisors), valued at $313M. Across recent filings, tracked investors recorded 4 new positions, 0 increased, 0 reduced, and 1 exited. All data sourced from SEC 13F filings.

Tracked investors reporting HUM

Investor	Firm	Shares	Market value	% of portfolio	As of
Ken Griffin	Citadel Advisors	1.8M	$312.7M	0.05%	Mar 31, 2026
Steve Cohen	Point72 Asset Management	54.6K	$9.5M	0.01%	Mar 31, 2026
Izzy Englander	Millennium Management	441.4K	$76.5M	0.03%	Mar 31, 2026
Stanley Druckenmiller	Duquesne Family Office	137.5K	$23.8M	0.71%	Mar 31, 2026
George Soros	Soros Fund Management	67.6K	$11.7M	0.13%	Mar 31, 2026
Ray Dalio	Bridgewater Associates	6.6K	$1.7K	0.00%	Sep 30, 2025

Ken GriffinMar 31, 2026
Citadel Advisors
Shares
1.8M
Value
$312.7M
% Portfolio
0.05%
Steve CohenMar 31, 2026
Point72 Asset Management
Shares
54.6K
Value
$9.5M
% Portfolio
0.01%
Izzy EnglanderMar 31, 2026
Millennium Management
Shares
441.4K
Value
$76.5M
% Portfolio
0.03%
Stanley DruckenmillerMar 31, 2026
Duquesne Family Office
Shares
137.5K
Value
$23.8M
% Portfolio
0.71%
George SorosMar 31, 2026
Soros Fund Management
Shares
67.6K
Value
$11.7M
% Portfolio
0.13%
Ray DalioSep 30, 2025
Bridgewater Associates
Shares
6.6K
Value
$1.7K
% Portfolio
0.00%

Recent activity

Investor	Action	Δ %	Current value	Filing date
George Soros	New	—	$12.9M	Feb 13, 2026
George Soros	New	—	$11.7M	May 15, 2026
Stanley Druckenmiller	New	—	$23.8M	May 15, 2026
Ray Dalio	Sold	-100.00%	$0	Feb 13, 2026
Ray Dalio	New	—	$1.7K	Nov 13, 2025

George Soros
New
$12.9MFeb 13, 2026
George Soros
New
$11.7MMay 15, 2026
Stanley Druckenmiller
New
$23.8MMay 15, 2026
Ray Dalio
Sold
$0(-100.00%)Feb 13, 2026
Ray Dalio
New
$1.7KNov 13, 2025

Frequently asked questions

How many institutional investors hold HUM?: 6 tracked institutional investors disclosed a position in HUM (HUMANA INC) in their most recent 13F filing.
Who is the largest institutional holder of HUM?: Ken Griffin, Citadel Advisors, holds the largest disclosed position in HUM, valued at $313M.
Did institutional ownership of HUM increase or decrease?: Across recent 13F filings, tracked investors recorded 4 new positions, 0 increased, 0 reduced, and 1 fully exited HUM.
What sector is HUM in?: HUMANA INC is classified in the Health Care GICS sector, Healthcare Plans industry.
Where does this HUM ownership data come from?: SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.